iRadimed (IRMD)
(Delayed Data from NSDQ)
$41.86 USD
+0.39 (0.94%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $41.69 -0.17 (-0.41%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
IRMD 41.86 +0.39(0.94%)
Will IRMD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IRMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IRMD
Acadia Healthcare (ACHC) Opens Facility to Serve California
UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS
IRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Centene's (CNC) Ambetter Enhances Offerings With Broward Health
Centene (CNC) Wins Contract From Arizona's Medicaid Agency
5 Small Hidden Gems for the Rest of 2023
Other News for IRMD
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
iRadimed resumed at Roth MKM as a buy as only provider of MRI-compatible IV pumps
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Iradimed (IRMD)
IRADIMED files to offer common stock
iRadimed files $75M common stock offering